Safe Orthopaedics S.A.
ALSAF.PA · PAR
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | €0 | €0 | €0 | €0 |
| % Growth | -0.9% | 28.7% | 24.5% | – |
| Cost of Goods Sold | €0 | €0 | €0 | €0 |
| Gross Profit | €0 | -€0 | -€0 | -€0 |
| % Margin | 74.4% | -74.4% | -126% | -138.1% |
| R&D Expenses | €0 | €0 | €0 | €0 |
| G&A Expenses | €0 | €0 | €0 | €0 |
| SG&A Expenses | €0 | €0 | €0 | €0 |
| Sales & Mktg Exp. | €0 | €0 | €0 | €0 |
| Other Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Expenses | €0 | €0 | €0 | €0 |
| Operating Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -137.3% | -101.7% | -166.5% | -182.3% |
| Other Income/Exp. Net | -€0 | -€0 | €0 | -€0 |
| Pre-Tax Income | -€0 | -€0 | -€0 | -€0 |
| Tax Expense | -€0 | €0 | €0 | -€0 |
| Net Income | -€0 | -€0 | -€0 | -€0 |
| % Margin | -3,536% | -118.8% | -147.3% | -227.1% |
| EPS | -2,706,764 | -96,154 | -92,620 | -227,853,436 |
| % Growth | -2,715% | -3.8% | 100% | – |
| EPS Diluted | -2,348,260 | -56,972 | -54,878 | -227,853,436 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | -€0 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €0 | €0 | €0 | €0 |
| EBITDA | -€0 | -€0 | -€0 | -€0 |
| % Margin | -4,615.7% | -96% | -114.2% | -188.1% |